Personalized Medicine- Are We There Yet?
May 14, 2010
- Fairbanks Hall
- Primary Sponsors
- Supporting Sponsors
- Indiana University School of Medicine
Indiana Clinical Translational Sciences Institute
Notre Dame University
Personalized Medicine is the next “big thing” in life sciences. Actually, it has been here for a while but the clear pathway for even more effective and efficient personalized or tailored medicine is now before us. Much like advances seen over the years with the adoption of the computer and its many applications, and the Internet, the life sciences industry will see dramatic and creative utilization of the human genome map, health informatics and technology, and a much more effective utilization of diagnostic devices and biomarkers with pharmaceuticals. The result will be a “win-win-win-win-win” for the patient, the doctor, the hospital, the device and diagnostic manufacturers, pharma and the biotech industries, the government or private reimbursers and, of course, the taxpayer. This conference will present interesting and exciting developments that are occurring both here in Indiana and around the globe and review how the state is uniquely situated to be one of the world’s leaders in Personalized Medicine.
8:00 am – 9:00 am Registration and Breakfast 9:00 am – 9:30 am Overview and Welcome - Personalized Medicine: Health and IT Enablers Welcome: Daniel F. Evans, President/CEO, Clarian Health Partners Inc. Overview: Charles Kennedy, M.D., Vice President, Health Information Technology, Wellpoint, Inc. 9:30 am – 10:30 am Keynote Presentation - Personalized Medicine: The Big Picture Introduction: Harry L. Gonso, Partner, Ice Miller LLP Keynote Speaker: John C. Lechleiter, PhD, Chairman, President and CEO, Eli Lilly and Company Q&A 10:30 am – 10:45 am Break 10:30 am – 12:00 pm Panel Presentation - The Science Behind the Business of Personalized Medicine Moderator: Jane F. Barlow, M.D., M.P.H., MBA,Vice President, Medical Strategy & Clinical Quality, Personalized Medicine, Solutions, Medco, Inc. Panel Members: George W. Sledge, Jr., M.D.,Ballve-Lantero Professor, IU School of Medicine & Clinical TeamMember, Indiana University Melvin and Bren Simon Cancer Center Mark A. Suckow, D.V.M., Director, Freimann Life Science Center, Research Associate Professor, Department of Biological Sciences, University of Notre Dame Philip S. Low, PhD, Ralph S. Corley Distinguished Professor-Biochemistry, Purdue University 12:00 pm – 1:30 pm Lunch & Networking Introduction: George W. Sledge, Jr., M.D. Speaker: Leroy Hood, M.D., PhD, President, Institute for Systems Biology 1:30 pm – 3:00 pm Panel Presentation - The Emergence of Personalized Medicine (P4) and How it Will Advance the Medicine of the Future Moderator: R. Matthew Neff, President, Clarian Health Ventures, Inc. Panel Members: Tiffany Olson, Vice President of Diagnostics, Eli Lilly and Company P. Ron Ellis, President, Endocyte, Inc. Richard H. Selinfreund, PhD, President, Companion Diagnostics, Inc. Linda H. Malkas, PhD, Founder, CS-Keys, Inc. and Syntherix, Inc. 3:00 pm - 3:15 pm Wrap-up Comments David L. Johnson, President, CEO, BioCrossroads 3:15 pm - 3:30 pm Announcement of Topics for 2010-2011 George Telthorst, Director, Center for the Business of Life Sciences, IU Kelley School of Business